title: Comments on 'competing designs for drug combination in phase I dose-finding clinical trials' by M-K. Riviere, F. Dubois, and S. Zohar.
authors.affiliation: Department of Statistics and Actuarial Science, The University of Hong Kong, Pokfulam Road, Hong Kong.
authors.forename: Guosheng
authors.initials: G
authors.lastname: Yin
authors.forename: Ruitao
authors.initials: R
authors.lastname: Lin
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017321:Clinical Trials, Phase I as Topic / Q000379:methods*; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D006801:Humans; D020714:Maximum Tolerated Dose
chemical_list: D000970:Antineoplastic Agents; D004338:Drug Combinations